Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.440
-0.110 (-7.10%)
At close: Jan 8, 2025, 4:00 PM
1.480
+0.040 (2.78%)
After-hours: Jan 8, 2025, 4:27 PM EST
Werewolf Therapeutics Stock Forecast
HOWL's stock price has decreased by -73.13% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for HOWL stock have an average target of 13.5, with a low estimate of 12 and a high estimate of 15. The average target predicts an increase of 837.50% from the current stock price of 1.44.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 19, 2024.
Analyst Ratings
The average analyst rating for HOWL stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +941.67% | Nov 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +941.67% | Jul 2, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +733.33% | Jun 26, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +941.67% | Jun 26, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +733.33% | Jun 4, 2024 |
Financial Forecast
Revenue This Year
1.92M
from 19.94M
Decreased by -90.39%
Revenue Next Year
2.57M
from 1.92M
Increased by 34.17%
EPS This Year
-1.59
from -1.05
EPS Next Year
-1.88
from -1.59
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 3.0M | 9.6M | 52.5M | |||
Avg | 1.9M | 2.6M | 10.2M | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -84.7% | 400.1% | 1,941.2% | |||
Avg | -90.4% | 34.2% | 296.6% | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -1.39 | -1.02 | -0.82 | |||
Avg | -1.59 | -1.88 | -1.69 | |||
Low | -1.94 | -4.07 | -3.33 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.